⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BIIB News
Biogen Inc. Common Stock
FDA approves Leqembi Iqlik® (lecanemab-irmb) subcutaneous injection as a starting dose for early Alzheimer's disease
prnewswire.com
BIIB
FDA Approves LEQEMBI IQLIK® (lecanemab-irmb) Subcutaneous Injection as an Initiation Dose for Early Alzheimer’s Disease
globenewswire.com
BIIB
FDA Approves LEQEMBI IQLIK® (lecanemab-irmb) Subcutaneous Injection as an Initiation Dose for Early Alzheimer's Disease
prnewswire.com
BIIB
McKinney's 2026 Food & Beverage Trends Report Sees Consumers Reclaiming Control
prnewswire.com
BIIB
SHW
SMG
SBUX
PG
Stoke Therapeutics Appoints Thomas McCauley, Ph.D., as Chief Scientific Officer
businesswire.com
STOK
BIIB
The 43rd National Pharmaceutical Industry Information Annual Conference and the 2026 Beijing · Changping Life Science Forum Held in Beijing
globenewswire.com
DHR
BIIB
BMY
GILD
MRK
PFE
REGN
SNY
XOM
LLY
ABBV
AMGN
AZN
JNJ
NVS
TEVA
VRTX
NVDA
GOOG
MSFT
As Enterprises Move AI Agents Into Production, OpenBox AI and Temporal Introduce Runtime Governance for Long-Running Agents
prnewswire.com
NFLX
SNOW
CHKP
DDOG
CRM
S
AMZN
GOOG
MSFT
IBM
ORCL
CSCO
INTC
NVDA
AMD
META
ADBE
PYPL
CMCSA
VZ
T
BA
GE
CAT
DIS
MCD
KO
PEP
JNJ
PG
XOM
CVX
WMT
HD
UNH
MA
V
JPM
BAC
WFC
C
GS
MS
AXP
BLK
PRU
MET
AIG
CB
MSCI
SPGI
ICE
NDAQ
AMAT
MU
ASML
KLAC
ADSK
CDNS
MRVL
QCOM
TXN
LRCX
ADI
MCHP
NXPI
ON
ALGN
BIIB
GILD
AMGN
REGN
VRTX
BMY
PFE
MRK
ABBV
LLY
JAZZ
AZN
SNY
NVS
TEVA
ACN
TMO
ISRG
DASH
UBER
LYFT
GOOGL
AAPL
TSLA
GM
F
RIVN
LCID
NIO
XPEV
PLTR
SMCI
CRWD
PANW
SNPS
MDT
EW
ABT
CI
HUM
CNC
ETSY
BKNG
EXPE
MAR
HLT
IHG
WYNN
LVS
MGM
CCL
RCL
NCLH
AAL
UAL
DAL
LUV
ALK
JBLU
New clinical data on the Leqembi® subcutaneous autoinjector presented at AAIC® 2026 support similar efficacy and safety to IV formulation in early Alzheimer's disease
prnewswire.com
BMY
BIIB
New clinical data on the Leqembi® subcutaneous autoinjector presented at AAIC® 2026 support similar efficacy and safety to IV formulation in early Alzheimer's disease
prnewswire.com
BIIB
LEQEMBI® Subcutaneous Autoinjector Clinical Data Supports Similar Efficacy and Safety to IV Formulation in Early Alzheimer’s Disease Presented at the Alzheimer’s Association International Conference® (AAIC®) 2026
globenewswire.com
BIIB